On ECHEMI
Home > Drugs > Postmenopausal cervical cancer
Postmenopausal cervical cancer
The highest risk of gynecological malignancies occurs during the perimenopausal and postmenopausal years. Cervical cancer is one of the main malignant tumors that endanger the health of women. During this period, women's ovarian function gradually declines and eventually fails; estrogen levels decrease, reproductive organs atrophy and age, and the entire body gradually ages; immune function declines, and the influence of various carcinogenic factors increases the incidence of malignant tumors, among which cervical cancer is the most common.
  • Site of disease:

    Uterus
  • Infectious :

    Not contagious
  • Frequent population:

    Postmenopausal women
  • Related symptoms:

    Increased leucorrhea vaginal bleeding cancerous ureteral stenosis cachexia increased leucorrhea
  • Concurrent disease:

Related Drugs
Glyphosate mustard tablets
Indication: Currently, it is mainly used topically to treat cancerous ulcers such as breast cancer and cervical cancer.
Manufacturer:

Jilin Jiatai Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.